Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,733 | 99,937 | -73,169 | -62,967 | -22,811 |
| Depreciation Amortization | 5,956 | 4,737 | 4,501 | 2,548 | 391 |
| Accounts receivable | -8,622 | -16,803 | 561 | 1,073 | -265 |
| Accounts payable and accrued liabilities | 1,528 | -218 | 2,621 | 186 | 590 |
| Other Working Capital | -5,325 | -7,774 | 897 | 5,229 | -3,040 |
| Other Operating Activity | -6,509 | 24,769 | 6,597 | 5,373 | 2,620 |
| Operating Cash Flow | $-107,705 | $104,648 | $-57,992 | $-48,558 | $-22,515 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 105,279 | -266,080 | 2,370 | 27,537 | -163,278 |
| PPE Investments | -11,720 | -13,278 | -7,160 | -8,149 | -522 |
| Investing Cash Flow | $93,559 | $-279,358 | $-4,790 | $19,388 | $-163,800 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,376 | 205,062 | 85,043 | 179 | 107 |
| Other Financing Activity | 0 | -619 | -445 | -60 | 239,203 |
| Financing Cash Flow | $8,376 | $204,443 | $84,598 | $119 | $239,310 |
| Beginning Cash Position | 76,614 | 46,881 | 25,065 | 54,116 | 1,121 |
| End Cash Position | 70,844 | 76,614 | 46,881 | 25,065 | 54,116 |
| Net Cash Flow | $-5,770 | $29,733 | $21,816 | $-29,051 | $52,995 |
| Free Cash Flow | |||||
| Operating Cash Flow | -107,705 | 104,648 | -57,992 | -48,558 | -22,515 |
| Capital Expenditure | -11,720 | -13,278 | -7,160 | -8,149 | -522 |
| Free Cash Flow | -119,425 | 91,370 | -65,152 | -56,707 | -23,037 |